conantokin-t has been researched along with Substance-Withdrawal-Syndrome* in 2 studies
2 other study(ies) available for conantokin-t and Substance-Withdrawal-Syndrome
Article | Year |
---|---|
Con-T[M8Q] potently attenuates the expression and development of morphine tolerance in mice.
As a variant of peptide conantokin-T (con-T), con-T[M8Q] is derived from the venom of Conus tulipa. Our previous study has demonstrated that con-T[M8Q] selectively targets N-methyl-d-aspartate receptor (NMDAR) NR2B subunit. In the present study, we determined the effects of con-T[M8Q] on the expression and development of morphine tolerance using hot plate test and acetic acid writhing test. Our results demonstrated that con-T[M8Q] could efficiently attenuate the expression and development of morphine analgesic tolerance in mice at low doses (5-20nmol/kg), and it exhibited more potent effects compared with ifenprodil, a typical small-molecule antagonist of NMDAR. In addition, low doses of con-T[M8Q] (5-20nmol/kg) did not cause drug resistance and apparent analgesic activity compared with morphine. Taken together, con-T[M8Q] could be a promising new candidate in attenuating morphine tolerance. Topics: Analgesics, Opioid; Animals; Conotoxins; Drug Tolerance; Female; Intercellular Signaling Peptides and Proteins; Male; Mice; Mollusk Venoms; Morphine; Naloxone; Narcotic Antagonists; Pain Measurement; Pain Threshold; Peptides; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2015 |
Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice.
The biochemical processes underlying opiate addiction are complex, but n-methyl-d-aspartate receptor (NMDAR) dysfunction appears to be one contributing factor. NMDAR antagonists, including MK-801 and memantine, have previously been shown to assuage symptoms stemming from opiate withdrawal. The conantokins are a small family of naturally occurring peptide toxins known to specifically antagonize the NMDAR. In the present study, the effects of wild-type and variant conantokins on the suppression of naloxone-induced jumping in morphine-dependent mice were evaluated. Our results demonstrate that NR2B-selective conantokins, viz., con-G, con-G[S(16)Y] and con-G[gamma(7)K], are potent inhibitors of naloxone-induced jumping at low doses (2-15 nmol/kg) compared with con-T, con-R[1-17], and small-molecule antagonists of the NMDAR, including the NR2B-selective agent, ifenprodil. We conclude that the NR2B-selective conantokins may find utility as neuropharmacological tools for probing NMDAR-related mechanisms of opiate dependence. Topics: Animals; Conotoxins; Intercellular Signaling Peptides and Proteins; Male; Mice; Mollusk Venoms; Morphine Dependence; Naloxone; Narcotic Antagonists; Peptides; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Substance Withdrawal Syndrome | 2006 |